Edwards Lifesciences today shared new data demonstrating successful outcomes with its mitral and tricuspid therapies.
The results of a new clinical trial have overturned the “wait and see” approach that cardiologists have long favored for symptom-free patients. By Benjamin Mueller For decades, people with failing ...
CHICAGO, April 18 (Reuters) - Edwards Lifesciences Corp said on Friday the first U.S. patients had received its heart valve implant to address a congenital condition in which the valve between the ...
MedPage Today on MSN
Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial
In ENCIRCLE, TMVR was performed in very ill patients with symptomatic mitral valve disease unsuitable for surgery or ...
Abbott's heart valve was approved by the FDA this year. For her family, 3-year-old Sadie Rutenberg is living proof that medical miracles are real. For the first year of her life, the Seattle baby was ...
There are striking inequalities in the provision of major (aortic) heart valve replacement surgery across England, with women, Black and Asian people, and those living in areas of deprivation much ...
ATLANTA — Channel 2 consumer adviser Clark Howard has been telling us how to save money for more than three decades. Now he has some advice for our health. On Wednesday, Howard will have surgery for a ...
CHICAGO, April 18 (Reuters) - Edwards Lifesciences Corp said on Friday the first U.S. patients received its heart valve implant to address a congenital condition in which the valve between the right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results